Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
11.49
-0.52 (-4.33%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Cogent Biosciences Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Cogent Biosciences stock have an average target of 14.5, with a low estimate of 10 and a high estimate of 19. The average target predicts an increase of 26.20% from the current stock price of 11.49.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for COGT stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +39.25% | Oct 24, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $13 → $15 | Strong Buy | Maintains | $13 → $15 | +30.55% | Sep 24, 2024 |
| Baird | Baird | Hold Maintains $8 → $10 | Hold | Maintains | $8 → $10 | -12.97% | Sep 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $19 → $17 | Strong Buy | Maintains | $19 → $17 | +47.95% | Sep 3, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $22 → $19 | Buy | Maintains | $22 → $19 | +65.36% | Aug 7, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.37
from -2.42
EPS Next Year
-2.34
from -2.37
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 205.4M | ||
| Avg | n/a | n/a | 77.6M | ||
| Low | n/a | n/a | 2.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.14 | -1.67 | -0.60 | ||
| Avg | -2.37 | -2.34 | -1.62 | ||
| Low | -2.51 | -2.76 | -2.52 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.